An enzyme-linked immunosorbent assay (ELISA) for Clostridium botulinum type A and type B toxins was assessed for diagpiostic accuracy in cases of infant botulism. This test was positive in all 22 cases confirmed by the conventional tests, which included the mouse lethality assay and stool culture. Stool specimens from five cases were positive by culture, but the mouse lethality bioassay was either negative or toxicity was judged nonspecific since it could not be neutralized by specific antitoxin. The positive ELISA results in these specimens suggeste4 that this assay may be more reliable, in some cases, than the mouse bioassay. Of the 21 fecal specimens from suspected foodborne cases, 2 contained botulinal toxin demonstrable by the mouse assay and the ELISA. With regard to specificity, 35 fecal specimens from infants and 19 from suspected foodborne cases which were negative in the bioassay for botulinal toxins A and B were also negative in the ELISA. antitoxins, we developed a sensitive enzyme-linked immunosorbent assay (ELISA) for detection of C. botulinum toxins A and B. The present report concerns the application of these assays with stool specimens from infants with suspected botulism and a preliminary investigation of fecal specimens from suspected cases of foodborne botulism.
Infant botulism is an enteric disease that results from in vivo production of neurotoxin by Clostridiium botiulinium, which colonizes the intestjnal tract of susceptible infants 1 to 9 months old (1) . Virtually all cases have been associated with C. botulinlum type A or type B (4, 8, 11) ; type F has been implicated in only one case (9) . The diagnosis of infant botulism can be cstablished by demonstration of botulinal toxin and C. botulinulm in feces of an infant exhibiting typical signs and symptoms Qf the disease (8, 11) . The antitoxins, we developed a sensitive enzyme-linked immunosorbent assay (ELISA) for detection of C. botulinum toxins A and B. The present report concerns the application of these assays with stool specimens from infants with suspected botulism and a preliminary investigation of fecal specimens from suspected cases of foodborne botulism.
MATERIALS AND METHODS Fecal specimens. Seventy-eight fecal specimens that had been examined for diagnostic confirmation of botulismn by mouse bioassay at the Centers for Disease Control, Atlanta, Ga., were used for evaluation of the ELISA system. These included 57 specimens from infants and children less than 28 months old, one from a 9-year-old child, 2 from teenagers, and 18 from adults (see Ta4les 3 and 4). The specimens from persons over 28 months old were from patients suspected of suffering from foodborne botulism. Two additional specimens (JHIB1 and JHIB2) were from cases of infant botulism confirmed by mouse assay at Johns Hopkins Hospital, Baltimore, Md. (13) . Laboratory confirmation of the presence of botulinum toxin in the JHIB1 specimen was achieved after dialysis of the fecal extract against phosphate buffer (Dezfulian and Bartlett, in press) .
All specimens had been tested for toxin by mouse assay and cultured for C. botutlinium by methods published elsewhere (7, 8 Organisms. Three isolates of C. botlinuim type A (strains A28, alOK, and a3K) were obtained from the stock collection of the Centers for Disease Control. Details regarding confirmation of their identity have been described previously (6) . The centrifuged supernatant of a 4-day-old bacterial culture was filtered through a 0.45-p.m Millipore filter, and the filtrate was used for the detection of toxin by ELISA.
Antitoxin. Type A, type B, and polyvalent (A, B, C, D. E, and F) diagnostic botulinal antitoxins were obtained from the Centers for Disease Control. Antigens to produce these antitoxins in burros were the partially purified toxoid prepared for human immunization (3). Rabbit antitoxins specific for botulinal toxins A and B were prepared by the method described previously (5) . The optimal dilutions of rabbit and burro antitoxins used for coating wells for the ELISA were determined by checkerboard titration.
ELISA. The ELISA procedure described by Voller et al. (15) was adapted with some modifications (5, 16) . Polyvinyl U-bottomed microtiter plates (Dynatech Laboratories, Inc., Alexandria, Va.) were coated with 100 pl. of a 1:5,000 dilution of burro type A, type B, or polyvalent botulinal antitoxins in 0.05 M carbonate buffer (pH 9.6). Blank wells were coated with normal horse serum. The specificity of the test system was not affected by the type of antitoxin used, but for the sake of convenience, wells were usually coated with the polyvalent antitoxin. After overnight incubation at 4°C, the coated plates were either used immediately or stored at 4°C and used within 2 weeks. Before the specimens were tested, the coated plates were washed 5 times with phosphate-buffered saline containing 0.05% Tween 20 (PBS-T). Unless otherwise specified, a 25-[tl sample of the fecal extract was added to appropriate wells containing 75 pL. of 40% fetal bovine serum (FBS) in PBS-T with 0.05% gelatin (PBS-TG). After an overnight incubation at 4°C, plates were washed as described above, and 100 p.1 of a 1:500 dilution of rabbit type A or type B botulinal antitoxin in PBS-TG was added. Plates were incubated for 90 min at 37°C and washed S times with PBS-T. A 100-plI sample of a 1:1,000 dilution (in PBS-TG) of alkaline phosphatase-conjugated goat antirabbit immunoglobulin G (Miles Laboratories, Inc., Elkhart, Ind.) was added. After incubation at 37°C for 90 min, the excess conjugate was removed by washing, and 100 pL. of a 1-mg/ml solution of p-nitrophenyl phosphate (Sigma 104 phosphatase substrate) in diethanolamine buffer (pH 9.8) was added. Plates were incubated at room temperature for 60 min, and Effects of normal human feces and FBS on sensitivity of ELISA in detecting botulinal toxin. We examined the effects of human feces in our ELISA system by measuring the level of toxin in the presence and absence of normal human fecal extract. The dual effects of fecal extract and FBS on toxin detection were also tested. The extract was the centrifuged supernatant of a 1:4 suspension of a fecal specimen in PBS-TG from a healthy 10-month-old infant. Samples of 25 pl. of crude botulinal toxin (culture filtrate) were tested in ELISA after being mixed with 75 pl. of the fecal extract, the extract in 40% FBS, or PBS-TG. We also studied the effects of FBS on the sensitivity of ELISA in detecting C. botulinliti toxin in the stool of infants with a similar method. RESULTS
Interference of toxin detection in ELISA and its reversal by FBS. The absorbance values of ELISA were drastically reduced when the fecal extract was added to culture filtrates of C. botiulinumn isolates (Table 1) . FBS, on the other hand, partially blocked the fecal interference ( Table 1) . The sensitivity of ELISA in detecting C. botlulinlum toxins in fecal specimens was also improved when 40% FBS was used as a diluent (Table 2) .
ELISA compared with mouse bioassay and culture for evidence of botulism. Of 59 fecal specimens from cases of suspected infant botulism, 22 were positive for C. bottluinium or botulinal toxin A or B by conventional tests. These included 17 specimens that were positive by mouse bioassay for toxins A or B and 5 that were negative in mouse bioassay but positive by culture for C. hotuilinilmn type A or B. The mouse lethality test in four of these five cases showed nonspecific toxicity, indicating that the specimen was toxic to mice, but there was no neutralization with specific antitoxins. One specimen was culture positive for C. botillinilm type A and nontoxic to mice at the dilution tested. Two additional specimens were culture positive for C. botiulininm type F, and one of these was positive in mouse bioassay for the homologous toxin (Table 3) . Diagnostic limits for ELISA readings were based on absorbance values exceeding three deviations above the mean value of the negative specimens. (Table 3) with antitoxins for types A and B.
The 21 fecal specimens from suspected cases of foodborne botulism gave essentially zero ELISA readings with the exception of two (no. 42 and 83) which were the only toxinpositive specimens by mouse assay (Table 4) . For toxinnegative specimens, the average ELISA readings were -0.002 ± 0.006 for type A and -0.010 ± 0.020 for type B. In this case, absorbance values above 0.016 for type A and above 0.050 for type B were considered positive.
A comparison between the ELISA and combined testing by mouse assay and culture for all the fecal specimens is summarized in Table 5 . This shows that 24 of 25 specimens that were positive by conventional tests for C. botiulinium or botulinal toxin A or B were positive by ELISA. Of 55 specimens that were negative by conventional tests, 53 were negative by ELISA. Thus, sensitivity and specificity rates were both 96%.
DISCUSSION
Infant botulism was initially described in 1976 (11, 12) , has been recognized with increasing frequency, and now out- " This includes 19 specimens positive by mouse bioassay and 5 culturepositive specimens which, with direct testing of stool by mouse assay, showed nonspecific toxicity (4 specimens) or no toxicity (1 specimen).
h This specimen was culture positive but showed no toxicity in mice.
ranks foodborne cases as the most common form of botulism in the United States. Infant botulism may account for some cases of sudden infant death syndrome or "crib death" (2) . However, this is regarded as one end of a spectrum of disease in which many victims may have rather trivial symptoms, leading some authorities to conclude that the condition may be greatly underdiagnosed. Toxin detection in stool by mouse assay is currently the method of choice for confirmation of infant botulism (8, 11) . The ELISA described here offers an alternative test which, unlike mouse assay, can easily be carried out in routine clinical laboratories. However, because of the rarity of botulism, performance of this assay in such laboratories may not be justified. On the basis of the data presented, the ELISA appeared to be highly sensitive and reasonably specific for the detection of type A and type B botulinal toxins in fecal specimens. It was found positive in all specimens from infant botulism cases that were confirmed for C. botulinum toxin A or B by conventional tests. This included five fecal specimens which showed positive cultures but were either nontoxic in mice or showed toxicity that was judged nonspecific since it could not be neutralized by specific antitoxin. In an additional specimen, toxin neutralization was achieved after dialysis of the fecal extract. All of these specimens were positive by ELISA, indicating that this method may actually be more reliable, in some cases, than the conventional mouse assay. Two of the fecal specimens from suspected foodborne cases contained botulinal toxin demonstrable by the mouse assay, and both were positive by the ELISA. As an indication of the specificity of our method, all but two fecal specimens from suspected infants and foodborne cases that were negative in the bioassay for type A and type B botulinal toxin were also negative in the ELISA. The positive ELISA for two bioassay-negative specimens might reflect the presence of a "naturally formed" nonlethal toxoid or a nonspecific reaction.
Inclusion of FBS in fecal diluent was shown to improve the sensitivity of our in vitro system. This finding is in accordance with a recent report (14) that many fecal specimens contain interfering substances which reduce the sensitivity of ELISA for toxin A of C. difficile and some viral antigens. The interference is apparently caused by desorption of the immunoreactants from solid-phase surfaces and is partially reversed by FBS as well as by specific and nonspecific protease inhibitors (14) .
To achieve the highest sensitivity with limited amounts of the available specimens, we included an overnight incubation of the specimens at 4°C and an additional 4 to 5 h at 37°C for performing the subsequent steps. Insufficient quantities of stool did not allow testing of other alternative incubation schedules. Nevertheless, by using precoated plates and a shorter period for incubation of the specimens, one may be able to complete the assay within 6 h. Although our assay was also able to detect C. botiulinuim antigen in specimens obtained from two adults with foodborne disease, the number of positive specimens was insufficient to provide definitive conclusions concerning the reliability of the ELISA test for this type of specimen. The efficiency of the assay system for the detection of C. botiulinumn in foodborne cases, in food and in other environmental specimens, should be determined in additional studies.
Infant botulism remains an important cause of morbidity and mortality in the newborn. However, the disease is sufficiently rare in most areas so that the ELISA seems unnecessary for most laboratories, although it does appear appropriate for reference laboratories and those serving large pediatric populations. More widespread availability of this and other sensitive assays for the detection and identification of C. botiulinium toxins, including type F, in biological samples might facilitate efficient diagnosis and study of this infection. Of particular importance would be the determination of the contribution of this disease to infant mortality among children living in environments where C. botulinurm is highly prevalent.
